• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧保护治疗方案的选择决定了肿瘤光动力治疗的炎症反应和疗效。

Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.

作者信息

Henderson Barbara W, Gollnick Sandra O, Snyder John W, Busch Theresa M, Kousis Philaretos C, Cheney Richard T, Morgan Janet

机构信息

Department of Cellular Stress Biology and the Photodynamic Therapy Center, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA.

出版信息

Cancer Res. 2004 Mar 15;64(6):2120-6. doi: 10.1158/0008-5472.can-03-3513.

DOI:10.1158/0008-5472.can-03-3513
PMID:15026352
Abstract

The rate of light delivery (fluence rate) plays a critical role in photodynamic therapy (PDT) through its control of tumor oxygenation. This study tests the hypothesis that fluence rate also influences the inflammatory responses associated with PDT. PDT regimens of two different fluences (48 and 128 J/cm(2)) were designed for the Colo 26 murine tumor that either conserved or depleted tissue oxygen during PDT using two fluence rates (14 and 112 mW/cm(2)). Tumor oxygenation, extent and regional distribution of tumor damage, and vascular damage were correlated with induction of inflammation as measured by interleukin 6, macrophage inflammatory protein 1 and 2 expression, presence of inflammatory cells, and treatment outcome. Oxygen-conserving low fluence rate PDT of 14 mW/cm(2) at a fluence of 128 J/cm(2) yielded approximately 70-80% tumor cures, whereas the same fluence at the oxygen-depleting fluence rate of 112 mW/cm(2) yielded approximately 10-15% tumor cures. Low fluence rate induced higher levels of apoptosis than high fluence rate PDT as indicated by caspase-3 activity and terminal deoxynucleotidyl transferase-mediated nick end labeling analysis. The latter revealed PDT-protected tumor regions distant from vessels in the high fluence rate conditions, confirming regional tumor hypoxia shown by 2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl) acetamide staining. High fluence at a low fluence rate led to ablation of CD31-stained endothelium, whereas the same fluence at a high fluence rate maintained vessel endothelium. The highest levels of inflammatory cytokines and chemokines and neutrophilic infiltrates were measured with 48 J/cm(2) delivered at 14 mW/cm(2) ( approximately 10-20% cures). The optimally curative PDT regimen (128 J/cm(2) at 14 mW/cm(2)) produced minimal inflammation. Depletion of neutrophils did not significantly change the high cure rates of that regimen but abolished curability in the maximally inflammatory regimen. The data show that a strong inflammatory response can contribute substantially to local tumor control when the PDT regimen is suboptimal. Local inflammation is not a critical factor for tumor control under optimal PDT treatment conditions.

摘要

光传递速率(通量率)通过控制肿瘤氧合作用在光动力疗法(PDT)中起着关键作用。本研究检验了通量率也会影响与PDT相关的炎症反应这一假设。针对Colo 26小鼠肿瘤设计了两种不同通量(48和128 J/cm²)的PDT方案,使用两种通量率(14和112 mW/cm²)在PDT期间保持或耗尽组织氧。肿瘤氧合、肿瘤损伤的范围和区域分布以及血管损伤与通过白细胞介素6、巨噬细胞炎性蛋白1和2表达、炎性细胞的存在以及治疗结果所测量的炎症诱导相关。在128 J/cm²的通量下以14 mW/cm²的保氧低通量率进行PDT产生了约70 - 80%的肿瘤治愈率,而在112 mW/cm²的耗氧通量率下相同通量产生了约10 - 15%的肿瘤治愈率。如通过半胱天冬酶 - 3活性和末端脱氧核苷酸转移酶介导的缺口末端标记分析所示,低通量率诱导的凋亡水平高于高通量率PDT。后者揭示了在高通量率条件下远离血管的PDT保护的肿瘤区域,证实了通过2 -(2 - 硝基咪唑 - 1[H] - 基) - N -(3,3,3 - 三氟丙基)乙酰胺染色显示的区域肿瘤缺氧。低通量率下的高通量导致CD31染色的内皮消融,而相同通量在高通量率下维持血管内皮。在14 mW/cm²下递送48 J/cm²时测量到最高水平的炎性细胞因子、趋化因子和嗜中性粒细胞浸润(约10 - 20%治愈率)。最佳治愈性PDT方案(14 mW/cm²下128 J/cm²)产生的炎症最小。嗜中性粒细胞的耗竭并未显著改变该方案的高治愈率,但消除了最大炎症方案中的治愈率。数据表明,当PDT方案次优时,强烈的炎症反应可对局部肿瘤控制有显著贡献。在最佳PDT治疗条件下,局部炎症不是肿瘤控制的关键因素。

相似文献

1
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.氧保护治疗方案的选择决定了肿瘤光动力治疗的炎症反应和疗效。
Cancer Res. 2004 Mar 15;64(6):2120-6. doi: 10.1158/0008-5472.can-03-3513.
2
Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.光动力疗法会在肿瘤内氧气的空间分布中产生与光通量率相关的梯度。
Cancer Res. 2002 Dec 15;62(24):7273-9.
3
Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.测量光敏剂花菁染料缀合物中的花菁染料光漂白情况有助于优化光疗剂量,从而提高癌症的光动力疗法效果。
Molecules. 2018 Jul 24;23(8):1842. doi: 10.3390/molecules23081842.
4
Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice.辐照通量率对亚四(羟苯基)氯卟啉(mTHPC)致敏的裸鼠HT29异种移植瘤光动力治疗疗效及肿瘤氧合的影响。
Radiat Res. 2002 Sep;158(3):339-45. doi: 10.1667/0033-7587(2002)158[0339:eoifro]2.0.co;2.
5
Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.肿瘤血管对光动力疗法及抗血管生成剂5,6-二甲基呫吨酮-4-乙酸的反应:对联合治疗的启示
Clin Cancer Res. 2005 Jun 1;11(11):4241-50. doi: 10.1158/1078-0432.CCR-04-2703.
6
Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.一氧化氮合酶抑制增强小鼠光动力疗法抗肿瘤活性具有光通量率依赖性。
Photochem Photobiol. 1999 Jul;70(1):64-71.
7
The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.光通量率对肿瘤及正常组织光动力治疗反应的影响。
Photochem Photobiol. 1998 Apr;67(4):462-6.
8
Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.恶性间皮瘤的光动力疗法:优化治疗方案的临床前研究
Photochem Photobiol. 2001 Apr;73(4):410-7. doi: 10.1562/0031-8655(2001)073<0410:ptfmmp>2.0.co;2.
9
Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.光敏剂剂量对光动力疗法中fluence率反应的影响。 (注:fluence rate可能是“光通量率”等专业术语,这里直接保留英文未翻译,因为不太明确在该语境下准确的中文表述)
Photochem Photobiol. 2007 Sep-Oct;83(5):1040-8. doi: 10.1111/j.1751-1097.2007.00139.x.
10
Fluence rate as a modulator of PDT mechanisms.光通量率作为光动力疗法机制的调节剂。
Lasers Surg Med. 2006 Jun;38(5):489-93. doi: 10.1002/lsm.20327.

引用本文的文献

1
Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control.低剂量光动力疗法可促进胸部恶性肿瘤中血管E-选择素的表达,改善免疫浸润并控制肿瘤。
J Immunother Cancer. 2025 Jun 10;13(6):e009482. doi: 10.1136/jitc-2024-009482.
2
Heterogeneous tumor blood oxygenation dynamics during phototherapy deciphered with real-time label-free photoacoustic imaging.通过实时无标记光声成像解析光疗期间肿瘤的异质性血液氧合动力学。
NPJ Acoust. 2025;1(1):9. doi: 10.1038/s44384-025-00012-x. Epub 2025 Jun 4.
3
Image-based treatment planning for TLD1433 mediated intraoperative photodynamic therapy with an optical surface applicator-A translational rodent study.
基于图像的TLD1433介导的术中光动力疗法的治疗计划,采用光学表面施药器——一项啮齿动物转化研究
Photochem Photobiol. 2025 May 13. doi: 10.1111/php.14101.
4
SNAP-Tag-Based Recombinant Photoimmunotherapeutic Agents for the Selective Detection and Killing of Light-Accessible Melanotransferrin-Expressing Melanoma and Triple-Negative Breast Cancer.基于SNAP标签的重组光免疫治疗剂,用于选择性检测和杀伤可光接触的表达黑素转铁蛋白的黑色素瘤和三阴性乳腺癌。
Cancer Med. 2025 May;14(9):e70912. doi: 10.1002/cam4.70912.
5
State-of-the-art photodynamic therapy for malignant gliomas: innovations in photosensitizers and combined therapeutic approaches.恶性胶质瘤的前沿光动力疗法:光敏剂及联合治疗方法的创新
Explor Target Antitumor Ther. 2025 Mar 28;6:1002303. doi: 10.37349/etat.2025.1002303. eCollection 2025.
6
In vivo, online label-free monitoring of heterogenous oxygen utilization during phototherapy with real-time ultrasound-guided photoacoustic imaging.在体内,通过实时超声引导光声成像对光疗期间的异质氧利用进行在线无标记监测。
bioRxiv. 2024 Dec 3:2024.11.27.625759. doi: 10.1101/2024.11.27.625759.
7
Devices and Methods for Dosimetry of Personalized Photodynamic Therapy of Tumors: A Review on Recent Trends.肿瘤个性化光动力治疗剂量学的设备与方法:近期趋势综述
Cancers (Basel). 2024 Jul 8;16(13):2484. doi: 10.3390/cancers16132484.
8
EPR Monitoring of Oxygenation Levels in Tumors After Chlorophyllide-Based Photodynamic Therapy May Allow for Early Prediction of Treatment Outcome.基于叶绿素的光动力疗法后肿瘤氧合水平的 EPR 监测可能有助于早期预测治疗效果。
Mol Imaging Biol. 2024 Jun;26(3):411-423. doi: 10.1007/s11307-023-01886-7. Epub 2024 Jan 31.
9
Photodynamic Therapy as a Desirable Approach in the Treatment of Colorectal Cancer, with Special Focus on Photodynamic Nanotherapeutics in Immunotherapy.光动力疗法作为治疗结直肠癌的理想方法,特别关注免疫治疗中的光动力纳米疗法。
Curr Med Chem. 2024 Jan 24. doi: 10.2174/0109298673267788231208073338.
10
Photodynamic Therapy-Induced Anti-Tumor Immunity: Influence Factors and Synergistic Enhancement Strategies.光动力疗法诱导的抗肿瘤免疫:影响因素与协同增强策略
Pharmaceutics. 2023 Nov 11;15(11):2617. doi: 10.3390/pharmaceutics15112617.